Atlas Trials

A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

Clinical trial NCT02206152 · COMPLETED

Trial details

NCT number
NCT02206152
Sponsor
University of Minnesota
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 1 DiabetesHypoglycemia Unawareness
Start date
2015-02-01
Primary completion
2017-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.